BioNTech SE (BNTX)
91.83
-0.50 (0.54%)
Upcoming Events
Latest Headlines
BioNTech (BNTX) PT Lowered to $119 at Morgan Stanley
July 8, 2026 8:07 AM - StreetInsider
Form 3 BioNTech SE For: Jun 26 Filed by: Low-Friedrich Iris Katharina
June 26, 2026 9:11 AM - SEC Filing
Form 3 BioNTech SE For: Jun 26 Filed by: Schaffert Susanne
June 26, 2026 9:09 AM - SEC Filing
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
June 25, 2026 11:40 AM - StreetInsider
German government to drop variable drug discounting plans - Reuters
June 15, 2026 6:08 AM - StreetInsider
Form 6-K BioNTech SE For: Jun 08
June 8, 2026 8:01 AM - SEC Filing
Bernstein SocGen Group Reiterates Market Perform Rating on BioNTech (BNTX)
June 5, 2026 9:00 AM - StreetInsider
Lilly cuts Germany investment plan in half over healthcare reforms
June 3, 2026 1:17 PM - StreetInsider
The Multi-Billion-Dollar Search for Better Glioblastoma Treatments
June 3, 2026 9:29 AM - StreetInsider
Form 6-K BioNTech SE For: Jun 01
June 1, 2026 8:00 AM - SEC Filing
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
UBS Upgrades BioNTech (BNTX) to Buy
May 27, 2026 4:21 AM - StreetInsider
Form 6-K BioNTech SE For: May 22
May 22, 2026 8:03 AM - SEC Filing
BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting
May 22, 2026 5:00 AM - Globe NewsWire
Bernstein SocGen Group Starts BioNTech (BNTX) at Market Perform
May 21, 2026 4:24 PM - StreetInsider
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
JPMorgan Reinstates BioNTech (BNTX) at Neutral
May 20, 2026 4:30 AM - StreetInsider
Form 6-K BioNTech SE For: May 15
May 15, 2026 4:25 PM - SEC Filing
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
May 15, 2026 4:15 PM - Globe NewsWire
Form SCHEDULE 13G/A BioNTech SE Filed by: Sahin Ugur
May 15, 2026 4:07 PM - SEC Filing
Form SCHEDULE 13G/A BioNTech SE Filed by: ATHOS KG
May 14, 2026 5:23 PM - SEC Filing
Form 4 BioNTech SE For: May 12 Filed by: Zapata Gomez Ramon
May 13, 2026 4:09 PM - SEC Filing
Form 4 BioNTech SE For: May 12 Filed by: Ryan James Timothy Patrick
May 13, 2026 4:08 PM - SEC Filing
Form 4 BioNTech SE For: May 12 Filed by: Poetting Sierk
May 13, 2026 4:06 PM - SEC Filing
Form 4 BioNTech SE For: May 12 Filed by: Jimenez Kylie
May 13, 2026 4:04 PM - SEC Filing
Form 4 BioNTech SE For: May 12 Filed by: Hanekamp Annemarie
May 13, 2026 4:02 PM - SEC Filing
Form 144 BioNTech SE Filed by: Medine GmbH
May 12, 2026 6:57 PM - SEC Filing
Form 6-K BioNTech SE For: May 07
May 7, 2026 8:20 AM - SEC Filing
BioNTech authorizes $1 billion share repurchase program
May 7, 2026 6:45 AM - StreetInsider
BioNTech Announces New ADS Repurchase Program
May 7, 2026 6:45 AM - Globe NewsWire
BioNTech (BNTX) PT Lowered to $140 at Wells Fargo
May 6, 2026 8:43 AM - StreetInsider
BioNTech (BNTX) PT Lowered to $158 at Canaccord
May 6, 2026 6:51 AM - StreetInsider
BioNTech (BNTX) PT Lowered to $125 at BofA Securities
May 5, 2026 12:07 PM - StreetInsider
BioNTech SE (BNTX) Tops Q1 EPS by 20c, provides guidance
May 5, 2026 6:56 AM - StreetInsider
Form 6-K BioNTech SE For: Mar 31
May 5, 2026 6:50 AM - SEC Filing
Form 6-K BioNTech SE For: May 05
May 5, 2026 6:48 AM - SEC Filing
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
May 5, 2026 6:45 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on BioNTech (BNTX)
April 27, 2026 6:47 AM - StreetInsider
Form 4 BioNTech SE For: Apr 22 Filed by: Poetting Sierk
April 23, 2026 7:23 PM - SEC Filing
Full Article List
